Cbl-b-IN-8
Cbl-b-IN-8 (Compound 293) is a casitas B-lineage lymphoma-b (Cbl-b) and c-Cbl inhibitor with IC50s of 5.5 nM and 7.8 nM, respectively[1].
Product Specifications
CAS Number
2815223-33-5
UNSPSC
12352005
Target
E1/E2/E3 Enzyme
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/cbl-b-in-8.html
Solubility
10 mM in DMSO
Smiles
O=C1C2=CC(CN3[C@H](CN(CC3)C)C(C)C)=CC(C(F)(F)F)=C2CN1C4=CC(C5(COC5)CC6=NN=CN6C)=CC(OC7CCCC7)=N4
Molecular Formula
C35H44F3N7O3
Molecular Weight
667.76
References & Citations
[1]Jun Liang, et al. Lactams as cbl-b inhibitors. Patent WO2022169997A1.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
CST 6898S 100 µL
β-Catenin (L54E2) Mouse Monoclonal Antibody (PE Conjugate)
Sign In for Pricing
View Details 